Another Adalimumab Biosimilar Seems Set for Interchangeability
Trial data pave way for FDA approval
Source: medpagetoday.com
Page 3 - Roy Fleischmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roy Fleischmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roy Fleischmann Today - Breaking & Trending Today
Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis
But is Russian backing a problem for U.S. approval?
Source: medpagetoday.com
Rheumatologists: 'Asleep at the Wheel' in Using Treat-to-Target?
Rheumatologists debate whether problems in the implementation of a treat-to-target approach in patients with RA stem from the metrics used to define targets or rheumatologists' efforts to use them.
Source: medscape.com
Patients Interrupting DMARD Use Well Into the COVID-19 Pandemic
Rates of patients stopping disease-modifying antirheumatic drugs (DMARDs) have begun to rise after initially falling during the pandemic, with consequent rises in the incidence of disease flares.
Source: medscape.com
Galvani Bioelectronics Announces World's First Investigational Treatment of Rheumatoid Arthritis Using Splenic Nerve Stimulation
Successful implantation and treatment underway in world's first patient receiving experimental therapy for Rheumatoid Arthritis (RA) using splenic nerve stimulation Electrical stimulation
Source: finanznachrichten.de